Abstract
Compared with angiography alone, intravascular ultrasound (IVUS) provides far greater detail with regard to the entire coronary vessel. IVUS has given valuable insight into the mechanisms of coronary atherosclerosis, plaque rupture, and stabilization as well as bare metal and drug-eluting stent mechanisms of restenosis and thrombosis. Additionally, IVUS-derived principles of expansion, apposition, and lesion coverage can aid in optimizing stent deployment and acute procedural results. Ultimately, its use may prevent adverse events related to percutaneous revascularization.
Similar content being viewed by others
References and Recommended Reading
Mintz GS, Nissen SE, Anderson WD, et al.: American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 2001, 37:1478–1492.
Glagov S, Weisenberg E, Zarins CK, et al.: Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med 1987, 316:1371–1375.
Schoenhagen P, Ziada KM, Kapadia SR, et al.: Extent and direction of arterial remodeling in stable versus unstable coronary syndromes: an intravascular ultrasound study. Circulation 2000, 101:598–603.
Varnava AM, Mills PG, Davies MJ: Relationship between coronary artery remodeling and plaque vulnerability. Circulation 2002, 105:939–943.
Maehara A, Mintz GS, Bui AB, et al.: Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 2002, 40:904–910.
Yamagishi M, Terashima M, Awano K, et al.: Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol 2000, 35:106–111.
Rioufol G, Finet G, Ginon I, et al.: Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 2002, 106:804–808.
Rioufol G, Gilard M, Finet G, et al.: Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: long-term follow-up with intravascular ultrasound. Circulation 2004, 110:2875–2880.
Ohlmann P, Kim SW, Mintz GS, et al.: Cardiovascular events in patients with coronary plaque rupture and nonsignificant stenosis. Am J Cardiol 2005, 96:1631–1635.
Hong MK, Mintz GS, Lee CW, et al.: Serial intravascular ultrasound evidence of both plaque stabilization and lesion progression in patients with ruptured coronary plaques: effects of statin therapy on ruptured coronary plaque. Atherosclerosis 2007, 191:107–114.
Briguori C, Anzuini A, Airoldi F, et al.: Intravascular ultrasound criteria for the assessment of the functional significance of intermediate coronary artery stenoses and comparison with fractional flow reserve. Am J Cardiol 2001, 87:136–141.
Abizaid A, Mintz GS, Pichard AD, et al.: Clinical, intravascular ultrasound, and quantitative angiographic determinants of the coronary flow reserve before and after percutaneous transluminal coronary angioplasty. Am J Cardiol 1998, 82:423–428.
Abizaid AS, Mintz GS, Mehran R, et al.: Long-term follow-up after percutaneous transluminal coronary angioplasty was not performed based on intravascular ultrasound findings: importance of lumen dimensions. Circulation 1999, 100:256–261.
Fajadet J, Wijns W, Laarman GJ, et al.: Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation 2006, 114:798–806.
Stone GW, Moses JW, Ellis SG, et al.: Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med 2007, 356:998–1008.
Mintz GS: Mechanisms, prevention and treatment of restenosis. In Intracoronary Ultrasound. Edited by Mintz GS. London: Taylor and Francis; 2005:299–400.
Hoffmann R, Mintz GS, Dussaillant GR, et al.: Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996, 94:1247–1254.
Castagna MT, Mintz GS, Leiboff BO, et al.: The contribution of “mechanical” problems to in-stent restenosis: an intravascular ultrasonographic analysis of 1090 consecutive in-stent restenosis lesions. Am Heart J 2001, 142:970–974.
de Jaegere P, Mudra H, Figulla H, et al.: Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study). Eur Heart J 1998, 19:1214–1223.
Moses JW, Leon MB, Popma JJ, et al.: Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003, 349:1315–1323.
Weissman NJ, Koglin J, Cox DA, et al.: Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 2005, 45:1201–1205.
Roy P, Bonello L, de Labriolle A, et al.: Two-year outcome of patients treated with sirolimus-versus paclitaxel-eluting stents in an unselected population with coronary artery disease (from the REWARDS Registry). Am J Cardiol 2008, 102:292–297.
Hong MK, Mintz GS, Lee CW, et al.: Intravascular ultrasound predictors of angiographic restenosis after sirolimus-eluting stent implantation. Eur Heart J 2006, 27:1305–1310.
Sonoda S, Morino Y, Ako J, et al.: Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the SIRIUS trial. J Am Coll Cardiol 2004, 43:1959–1963.
Roy P, Waksman R: Intravascular ultrasound guidance in drug-eluting stent deployment. Minerva 2008, 56:67–77.
Sakurai R, Ako J, Morino Y, et al.: Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol 2005, 96:1251–1253.
Cutlip DE, Windecker S, Mehran R, et al.: Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007, 115:2344–2351.
Moreno R, Fernandez C, Hernandez R, et al.: Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005, 45:954–959.
Daemen J, Wenaweser P, Tsuchida K, et al.: Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007, 369:667–678.
Kastrati A, Mehilli J, Pache J, et al.: Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med 2007, 356:1030–1039.
Uren NG, Schwarzacher SP, Metz JA, et al.: Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Eur Heart J 2002, 23:124–132.
Cheneau E, Leborgne L, Mintz GS, et al.: Predictors of subacute stent thrombosis: results of a systematic intravascular ultrasound study. Circulation 2003, 108:43–47.
Fujii K, Carlier SG, Mintz GS, et al.: Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study. J Am Coll Cardiol 2005, 45:995–998.
Okabe T, Mintz GS, Buch AN, et al.: Intravascular ultrsound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol 2007, 100:615–620.
Tanabe K, Serruys PW, Degertekin M, et al.: Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation 2005, 111:900–905.
Hong MK, Mintz GS, Lee CW, et al.: Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation 2006, 113:414–419.
Siqueira DA, Abizaid AA, Costa Jde R, et al.: Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes. Eur Heart J 2007, 28:1304–1309.
Shah VM, Mintz GS, Apple S, Weissman NJ: Background incidence of late malapposition after bare-metal stent implantation. Circulation 2002, 106:1753–1755.
Hong MK, Mintz GS, Lee CW, et al.: Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation 2004, 109:881–886.
Cook S, Wenaweser P, Togni M, et al.: Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007, 115:2426–2434.
Cutlip DE, Baim DS, Ho KK, et al.: Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001, 103:1967–1971.
Wenaweser P, Rey C, Eberli FR, et al.: Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 2005, 26:1180–1187.
Iakovou I, Schmidt T, Bonizzoni E, et al.: Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005, 293:2126–2130.
Ong AT, Hoye A, Aoki J, et al.: Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol 2005, 45:947–953.
de Ribamar Costa J Jr, Mintz GS, Carlier SG, et al.: Intravascular ultrasonic assessment of stent diameters derived from manufacturers’ compliance charts. Am J Cardiol 2005, 96:74–78.
de Ribamar Costa J Jr, Mintz GS, Carlier SG, et al.: Intravascular ultrasound assessment of drug-eluting stent expansion. Am Heart J 2007, 153:297–303.
Cheneau E, Satler LF, Escolar E, et al.: Underexpansion of sirolimus-eluting stents: incidence and relationship to delivery pressure. Catheter Cardiovasc Interv 2005, 65:222–226.
Mintz GS, Weissman NJ: Intravascular ultrasound in the drug-eluting stent era. J Am Coll Cardiol 2006, 48:421–429.
Roy P, Okabe T, Pinto Slottow TL, et al.: Correlates of clinical restenosis following intracoronary implantation of drug-eluting stents. Am J Cardiol 2007, 100:965–969.
Roy P, Torguson R, Okabe T, et al.: Angiographic and procedural correlates of stent thrombosis after intracoronary implantation of drug-eluting stents. J Interv Cardiol 2007, 20:307–313.
Roy P, Steinberg DH, Sushinsky SJ, et al.: The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J 2008, 29:1851–1857.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Van Horn, S.E., Steinberg, D.H. Grayscale intravascular ultrasound: Current concepts in percutaneous coronary interventions. curr cardiovasc imaging rep 2, 259–267 (2009). https://doi.org/10.1007/s12410-009-0030-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12410-009-0030-9